LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma.
Cela I, Caponio VCA, Capone E, Pinti M, Mascitti M, Togni L, Lo Muzio L, Rubini C, De Laurenzi V, Lattanzio R, Perrotti V, Sala G.
Cela I, et al. Among authors: togni l.
Oral Dis. 2023 Aug 31. doi: 10.1111/odi.14719. Online ahead of print.
Oral Dis. 2023.
PMID: 37649401